The CRISPR-selective deletion of the CRNDE reduces MM cells proliferation, adhesion, and tumor growth by downregulating the expression of IL-6R, hence preventing the activation of IL-6/IL-6R pathway [38], essential for MM pathogenesis and progression [39]. This evidence concerns the gene IL6 and Miyoshi myopathy.